Centers for Medicare and Medicaid Services/ Coverage and Analysis Group

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Centers for Medicare and Medicaid Services/ Coverage and Analysis Group sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group: 1 sponsored US clinical trial, 1 recruiting.

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease, with 1 trials.

Mid-pack sponsor footprint

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Open and recent trials

1 total, page 1 of 1

RECRUITING

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

NCT06058234

Therapeutic Areas

Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease 1
Mild Alzheimer's Disease 1

What is open in the Centers for Medicare and Medicaid Services/ Coverage and Analysis Group pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share Centers for Medicare and Medicaid Services/ Coverage and Analysis Group1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
Centers for Medicare and Medicaid Services/ Coverage and Analysis Group sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Centers for Medicare and Medicaid Services/ Coverage and Analysis Group sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Centers for Medicare and Medicaid Services/ Coverage and Analysis Group page

1 registered trials is a research-attention snapshot, not an endorsement of Centers for Medicare and Medicaid Services/ Coverage and Analysis Group or any single study.

  • 1 of Centers for Medicare and Medicaid Services/ Coverage and Analysis Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease is the condition Centers for Medicare and Medicaid Services/ Coverage and Analysis Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Centers for Medicare and Medicaid Services/ Coverage and Analysis Group pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.